duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - gyógyszerek obstruktív légúti betegségek, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
denegis 37,5 mg retard kemény kapszula
egis gyógyszergyár zrt. - a venlafaxin -
denegis 75 mg retard kemény kapszula
egis gyógyszergyár zrt. - a venlafaxin -
denegis 150 mg retard kemény kapszula
egis gyógyszergyár zrt. - a venlafaxin -
venlagamma 37,5 mg retard kemény kapszula
wörwag pharma gmbh&co.kg - a venlafaxin -
venlagamma 75 mg retard kemény kapszula
wörwag pharma gmbh&co.kg - a venlafaxin -
venlagamma 150 mg retard kemény kapszula
wörwag pharma gmbh&co.kg - a venlafaxin -
venlaxgen 37,5 mg retard kemény kapszula
generics uk limited - a venlafaxin -
venlaxgen 75 mg retard kemény kapszula
generics uk limited - a venlafaxin -
venlaxgen 150 mg retard kemény kapszula
generics uk limited - a venlafaxin -